Navigation Links
Age No Bar to Aggressive Rx for Cardiogenic Shock
Date:2/16/2009

The heart condition is a major killer of people over the age of 75, researchers note

MONDAY, Feb. 16 (HealthDay News) -- Age shouldn't prevent the aggressive treatment of elderly patients with heart attack complicated by cardiogenic shock, Australian researchers report.

Cardiogenic shock (CS) occurs when the heart fails to supply enough blood to the body's organs. It is the most common cause of death after heart attack among Americans over the age of 75.

There's typically been widespread reluctance to use invasive treatments on elderly heart patients. However, this study found that elderly patients with heart attack complicated by CS who underwent percutaneous coronary intervention (PCI) had a one-year survival rate similar to that of younger patients.

"Elderly patients who are admitted to the hospital with massive heart attacks may still benefit from emergency coronary artery balloon angioplasty with stenting, despite their advanced age. Although mortality occurs in roughly half of patients in these high risk situations, without this aggressive treatment, the prospect of survival is very poor," study senior author David Clark, an interventional radiologist at Austin Hospital in Melbourne, said in an American College of Cardiology news release.

He and his colleagues analyzed data on 143 heart attack patients, including 45 elderly patients, treated between 2004 and 2007. The elderly patients were more likely to be female and to have hypertension, kidney failure, multi-vessel coronary artery disease and to have a had a previous heart attack.

There were no significant differences between the elderly and younger patients for in-hospital, 30-day and one-year death rates, the researchers reported in the February issue of the Journal of the American College of Cardiology: Cardiovascular Interventions.

"A patient's age in and of itself should not be used to deny someone more aggressive,
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Researchers discover metabolite linked to aggressive prostate cancer
2. Marijuana Linked to Aggressive Testicular Cancer
3. Aggressive Treatment Effective in Kids Brain Cancer
4. Gene mutations increase risk for aggressive prostate cancer
5. Global Health Community Commits Over $630 Million in Aggressive Push for Polio Eradication
6. Susan G. Komen for the Cure(R) and Triple Negative Breast Cancer Foundation Unite to Fight Aggressive Form of Breast Cancer
7. New insight into aggressive childhood cancer
8. Aggressive Therapy May Stem CF Progression in Infants
9. MedPro Imaging Continues Aggressive U.S. Expansion
10. Women with mitral valve prolapse are treated less aggressively than men and may be at high risk
11. Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Age No Bar to Aggressive Rx for Cardiogenic Shock
Age No Bar to Aggressive Rx for Cardiogenic Shock
Breaking Medicine Technology:Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 1For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 2For Patients With Irritable Bowel Syndrome 28IBS 29 iPhone to the Rescue 47442 3Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 1Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 2Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 3Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 4Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT 101 in Prostate Brain and Lung Cancers at 2009 ASCO Annu 12378 5Study shows gay couples want legal rights regardless of marriage 47439 1Study shows gay couples want legal rights regardless of marriage 47439 2